본문 바로가기
KERD
논문KCI 등재

The YTHDC1/GLUT3/RNF183 axis forms a positive feedback loop that modulates glucose metabolism and bladder cancer progression

Xin Jin|Yan Bin|Li Xurui|Peng Mou|Zuo Yali|Wang Yinhuai|Liu Pian|Ren Weigang
생화학분자생물학회 (Korean Society Of Biochemistry And Molecular Biology)|2023.12|Experimental and Molecular Medicine|제55권 |pp. 1145-1158|DOI 10.1038/s12276-023-00997-z

2

조회

0

다운로드

0

인용

0

참고문헌

주제분류생화학

초록

Aberrant glucose metabolism is a characteristic of bladder cancer. Hyperglycemia contributes to the development and progression of bladder cancer. However, the underlying mechanism by which hyperglycemia promotes the aggressiveness of cancers, especially bladder cancer, is still incompletely understood. N6-methyladenosine (m6A) modification is a kind of methylation modification occurring at the N6 position of adenosine that is important for the pathogenesis of urological tumors. Recently, it was found that the m6A reader YTHDC1 is regulated by high-glucose conditions. In our study, we revealed that YTHDC1 is not only regulated by high-glucose conditions but is also downregulated in bladder cancer tissue and associated with the prognosis of cancer. We also showed that YTHDC1 suppresses the malignant progression of and the glycolytic process in bladder cancer cells in an m6A-dependent manner and determined that this effect is partially mediated by GLUT3. Moreover, GLUT3 was found to destabilize YTHDC1 by upregulating RNF183 expression. In summary, we identified a novel YTHDC1/GLUT3/RNF183 feedback loop that regulates disease progression and glucose metabolism in bladder cancer. Collectively, this study provides new insight regarding the pathogenesis of bladder cancer under hyperglycemic conditions and might reveal ideal candidates for the development of drugs for bladder cancer.

Abstract

Aberrant glucose metabolism is a characteristic of bladder cancer. Hyperglycemia contributes to the development and progression of bladder cancer. However, the underlying mechanism by which hyperglycemia promotes the aggressiveness of cancers, especially bladder cancer, is still incompletely understood. N6-methyladenosine (m6A) modification is a kind of methylation modification occurring at the N6 position of adenosine that is important for the pathogenesis of urological tumors. Recently, it was found that the m6A reader YTHDC1 is regulated by high-glucose conditions. In our study, we revealed that YTHDC1 is not only regulated by high-glucose conditions but is also downregulated in bladder cancer tissue and associated with the prognosis of cancer. We also showed that YTHDC1 suppresses the malignant progression of and the glycolytic process in bladder cancer cells in an m6A-dependent manner and determined that this effect is partially mediated by GLUT3. Moreover, GLUT3 was found to destabilize YTHDC1 by upregulating RNF183 expression. In summary, we identified a novel YTHDC1/GLUT3/RNF183 feedback loop that regulates disease progression and glucose metabolism in bladder cancer. Collectively, this study provides new insight regarding the pathogenesis of bladder cancer under hyperglycemic conditions and might reveal ideal candidates for the development of drugs for bladder cancer.

참고문헌 (48)

  1. "National Cancer Institute (US)", 2002
  2. Crocetto, F., "Liquid biopsy in bladder cancer : state of the art and future perspectives", Crit. Rev. Oncol. Hematol, 170, pp.103577~ (2022)
  3. Konala, V. M., "Immunotherapy in bladder cancer", Am. J. Ther, 29, pp.e334~e337 (2022)
  4. Zhao, X., "Cigarette smoking and risk of bladder cancer : a dose-response meta-analysis", Int. Urol. Nephrol, 54, pp.1169~1185 (2022)
  5. Patel, V. G., "Treatment of muscle-invasive and advanced bladder cancer in 2020", CA Cancer J. Clin, 70, pp.404~423 (2020)
  6. Rhea, L. P., "Role of immunotherapy in bladder cancer", Cancer Treat. Res. Commun, 26, pp.100296~ (2021)
  7. Liu, X., "HBXIP accelerates glycolysis and promotes cancer angiogenesis via AKT", mTOR pathway in bladder cancer, 2021, pp.121, 104665~
  8. Warburg, O., "The metabolism of tumors in the body", J. Gen. Physiol, 8, pp.519~530 (1927)
  9. Dobbs, R., "Glucagon : role in the hyperglycemia of diabetes mellitus", Science, 187, pp.544~547 (1975)
  10. Mechanick, J. I, "Metabolic mechanisms of stress hyperglycemia", J. Parenter. Enter. Nutr, 30, pp.157~163 (2006)
  11. Fogar, P., "Transforming growth factor beta, fibrogenesis and hyperglycemia in patients with chronic pancreatitis", J. Med, 29, pp.277~287 (1998)
  12. Coughlin, S. S., "Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults", Am. J. Epidemiol, 159, pp.1160~1167 (2004)
  13. Jee, S. H., "Fasting serum glucose level and cancer risk in Korean men and women", JAMA, 293, pp.194~202 (2005)
  14. Tseng, C. H., "Age-related risk of mortality from bladder cancer in diabetic patients : a 12-year follow-up of a national cohort in Taiwan", Ann. Med, 41, pp.371~379 (2009)
  15. Lewis, J. D., "Risk of bladder cancer among diabetic patients treated with pioglitazone : interim report of a longitudinal cohort study", Diabetes Care, 34, pp.916~922 (2011)
  16. Lattermann, R., "Integrated analysis of glucose, lipid, and urea metabolism in patients with bladder cancer. Impact of tumor stage", Nutrition, 19, pp.589~592 (2003)
  17. Lee, Y. H., "Laminar shear stress inhibits high glucose-induced migration and invasion in human bladder cancer cells", In Vitro Cell Dev. Biol. Anim, 54, pp.120~128 (2018)
  18. Duan, W., "Hyperglycemia, a neglected factor during cancer progression", Biomed. Res. Int, 2014, pp.461917~ (2014)
  19. Wang, T., "The potential role of RNA N6-methyladenosine in cancer progression", Mol. Cancer, 19, pp.88~ (2020)
  20. He, L., "Functions of N6-methyladenosine and its role in cancer", Mol. Cancer, 18, pp.176~ (2019)
  21. Li, Y., "The potential roles of RNA N6-methyladenosine in urological tumors", Front. Cell Dev. Biol, 8, pp.579919~ (2020)
  22. Chen, X. Y., "The role of m(6)A RNA methylation in human cancer", Mol. Cancer, 18, pp.103~ (2019)
  23. Bornaque, F., "Glucose regulates m(6)A methylation of RNA in pancreatic islets", Cells, 11, pp.291~ (2022)
  24. Wang, Y., "m(6)A mRNA Methylation controls functional maturation in neonatal murine beta-cells", Diabetes, 69, pp.1708~1722 (2020)
  25. Liu, J., "METTL14 is essential for beta-cell survival and insulin secretion", Biochim. Biophys. Acta Mol. Basis Dis, 1865, pp.2138~2148 (2019)
  26. Liang, D., "m(6)A reader YTHDC1 modulates autophagy by targeting SQSTM1in diabetic skin", Autophagy, 18, pp.1318~1337 (2021)
  27. Yi, L., "The FOXM1", RNF26, Cell Death Dis, pp.2021, 12[DOI]
  28. Jin, X., "Phosphorylated RB promotes cancer immunity by inhibiting NFkappaB activation and PD-L1 expression", Mol. Cell, 73, pp.22~35 (2019)
  29. Hammer, M., "Hyperglycemia and cancer : a state-of-the-science review", Oncol. Nurs. Forum, 46, pp.459~472 (2019)
  30. Zhu, X., "YTHDC1-mediated VPS25 regulates cell cycle by targeting JAK-STAT signaling in human glioma cells", Cancer Cell Int, 21, pp.645~ (2021)
  31. Roundtree, I. A., "YTHDC1 mediates nuclear export of N(6)-methyladenosine methylated mRNAs", Elife, 6, pp.e31311~ (2017)
  32. Li, S., "Nuclear Aurora kinase A switches m(6)A reader YTHDC1 to enhance an oncogenic RNA splicing of tumor suppressor RBM4", Signal Transduct. Target. Ther, 7, pp.97~ (2022)
  33. Xiao, W., "Nuclear m(6)A Reader YTHDC1 regulates mRNA splicing", Mol. Cell, 61, pp.507~519 (2016)
  34. Hochrein, S. M., "The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming", Cell Metab, 34, pp.516~532 (2022)
  35. Libby, C. J., "A role for GLUT3 in glioblastoma cell invasion that is not recapitulated by GLUT1", Cell Adh. Migr, 15, pp.101~115 (2021)
  36. Tsai, T. H., "Overexpression of GLUT3 promotes metastasis of triple-negative breast cancer by modulating the inflammatory tumor microenvironment", J. Cell. Physiol, 236, pp.4669~4680 (2021)
  37. Fei, X., "MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression", FEBS Lett, 586, pp.392~397 (2012)
  38. Okamoto, T., "Hypertonicity-responsive ubiquitin ligase RNF183 promotes Na, K-ATPase lysosomal degradation through ubiquitination of its beta1 subunit", Biochem. Biophys. Res. Commun, 521, pp.1030~1035 (2020)
  39. Wu, Y., "Transmembrane E3 ligase RNF183 mediates ER stress-induced apoptosis by degrading Bcl-xL", Proc. Natl Acad. Sci. USA, 115, pp.E2762~E2771 (2018)
  40. Tracz, M., "Beyond K48 and K63 : non-canonical protein ubiquitination", Cell. Mol. Biol. Lett, 26, pp.1~ (2021)
  41. Lopata, A., "Ubiquitination in the ERAD Process", Int. J. Mol. Sci, 21, pp.5369~ (2020)
  42. Massari, F., "Metabolic phenotype of bladder cancer", Cancer Treat. Rev, 45, pp.46~57 (2016)
  43. Ancey, P. B., "Glucose transporters in cancer—from tumor cells to the tumor microenvironment", FEBS J, 285, pp.2926~2943 (2018)
  44. Dai, W., "GLUT3 induced by AMPK", CREB1 axis is key for withstanding energy stress and augments the efficacy of current colorectal cancer therapies, 2020, pp.5, 177~
  45. Sheng, Y., "A critical role of nuclear m6A reader YTHDC1 in leukemogenesis by regulating MCM complex-mediated DNA replication", Blood, 138, pp.2838~2852 (2021)
  46. Tang, S., "LINC00857 promotes cell proliferation and migration in colorectal cancer by interacting with YTHDC1 and stabilizing SLC7A5", Oncol. Lett, 22, pp.578~ (2021)
  47. Hou, Y., "YTHDC1-mediated augmentation of miR-30d in repressing pancreatic tumorigenesis via attenuation of RUNX1-induced transcriptional activation of Warburg effect", Cell Death Differ, 28, pp.3105~3124 (2021)
  48. Ma, S., "The interplay between m6A RNA methylation and noncoding RNA in cancer", J. Hematol. Oncol, 12, pp.121~ (2019)

관련 논문AI추천

Loss of YTHDC1 m6A reading function promotes invasiveness in urothelial carcinoma of the bladderErben Philipp, Koch Jonas, Lyko Frank, Michel Maurice Stephan, Neuberger Manuel, Nientiedt Malin, Rodríguez-Paredes Manuel, Schmidt Claudia, Xu Jinyun생화학분자생물학회 · Experimental and Molecular Medicine2025 · 제57권 The m6A writer RBM15 drives the growth of triple-negative breast cancer cells through the stimulation of serine and glycine metabolism이종호, Eyun Seong-il, Győrffy Balázs, Han Hee Dong, Ju Jin-Sung, Kim Eun-jeong, Kim Ho, Kim Seok-Ho, Lee Su Bin, Park Su Hwan, Park Yun-Yong, Woo Hyunmin, Yun Hye Jin생화학분자생물학회 · Experimental and Molecular Medicine2024 · 제56권 Augmentation of the RNA m6A reader signature is associated with poor survival by enhancing cell proliferation and EMT across cancer typesAn Joon-Yong, Cho Sung-Yup, Hwa Chanwoong, Jang Dongjun, Jang Giyong, Jung Hae Rim, Kim Jiwon, Kwon Obin, Lee Sang Eun, Lee Soojin, Oh Jaeik, Oh Yumi, Shin Seungjae생화학분자생물학회 · Experimental and Molecular Medicine2022 · 제54권 Hypoxia-induced circRNF13 promotes the progression and glycolysis of pancreatic cancerCui Jianhua, Guo Lihong, Guo Xingya, Jiang Weiliang, Li Kai, Shen Jie, Wang Chuanyang, Wan Rong, Xiao Wenqin, Zhao Qiuyan, Zhu Zhonglin, Zong Guanzhao생화학분자생물학회 · Experimental and Molecular Medicine2022 · 제54권 Deciphering the molecular mechanisms of epitranscriptome regulation in cancerJunho Choe, Seung Hun Han생화학분자생물학회 · BMB Reports2021 · 제54권 제2호Biological roles of the RNA m6A modification and its implications in cancerHong Juyeong, Lee Ji Hoon, Xu Kexin생화학분자생물학회 · Experimental and Molecular Medicine2022 · 제54권

이 간행물의 다른 논문 (225건)

Endothelial senescence in vascular diseases: current understanding and future opportunities in senotherapeutics김성영, Han Yeaeunpp. 1-12Grave-to-cradle: human embryonic lineage tracing from the postmortem bodyKu Eu Jeong, Choi Seock Hwan, Choi Yujin Angelina, Oh Ji Wonpp. 13-21Chromatin and noncoding RNA-mediated mechanisms of gastric tumorigenesisKim Tae-Hee, Loe Adrian Kwan Ho, Zhu Lexinpp. 22-31TPX2 prompts mitotic survival via the induction of BCL2L1 through YAP1 protein stabilization in human embryonic stem cellsCha Hyuk-Jin, Kim Yun-Jeong, Go Young-Hyun, 정호창, Kwon Eun-Ji, Kim Seong-Min, Cheong Hyun Sub, Kim Wantae, Shin Hyoung Doo, Lee Haeseungpp. 32-42ZBTB7A suppresses glioblastoma tumorigenesis through the transcriptional repression of EPB41L5Nam Hae Yun, 김성학, 김승후, 최경철, Park Seung-Ho, Song Ji-Hye, Jeong Ji-Hoon, Kim Hyunhee, Jeong Minseok, Kong Min-Jeong, Son Jihyun, Jeong Ji-Eunpp. 43-54
원문 보기